BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23458897)

  • 1. Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis.
    Qazi MR; Hassan M; Nelson BD; Depierre JW; Abedi-Valugerdi M
    Toxicol Lett; 2013 May; 219(1):1-7. PubMed ID: 23458897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both sub-acute, moderate-dose and short-term, low-dose dietary exposure of mice to perfluorooctane sulfonate exacerbates concanavalin A-induced hepatitis.
    Qazi MR; Hassan M; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicol Lett; 2013 Feb; 217(1):67-74. PubMed ID: 23237827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice.
    Qazi MR; Abedi MR; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Int Immunopharmacol; 2010 Nov; 10(11):1420-7. PubMed ID: 20816993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice.
    Son HY; Kim SH; Shin HI; Bae HI; Yang JH
    Arch Toxicol; 2008 Apr; 82(4):239-46. PubMed ID: 17874065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.
    Qazi MR; Bogdanska J; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Aug; 262(3):207-14. PubMed ID: 19540903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin aggravates immune-mediated liver injury in mice.
    Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
    Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.
    Bozza M; Bliss JL; Maylor R; Erickson J; Donnelly L; Bouchard P; Dorner AJ; Trepicchio WL
    Hepatology; 1999 Dec; 30(6):1441-7. PubMed ID: 10573523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).
    Qazi MR; Xia Z; Bogdanska J; Chang SC; Ehresman DJ; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Jun; 260(1-3):68-76. PubMed ID: 19464571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
    Gao M; Zhang J; Liu G
    Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
    Fullerton AM; Roth RA; Ganey PE
    Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
    Wang J; Sun R; Wei H; Dong Z; Tian Z
    Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
    Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
    J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8:2 Fluorotelomer alcohol causes immunotoxicity and liver injury in adult male C57BL/6 mice.
    Wang X; Kong B; He B; Wei L; Zhu J; Jin Y; Shan Y; Wang W; Pan C; Fu Z
    Environ Toxicol; 2019 Feb; 34(2):141-149. PubMed ID: 30536526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
    Shirin H; Bruck R; Aeed H; Hershkoviz R; Lider O; Kenet G; Avni Y; Halpern Z
    Liver; 1997 Dec; 17(6):275-80. PubMed ID: 9455732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
    Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice.
    Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A
    Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice.
    Zhang H; Gong Q; Li JH; Kong XL; Tian L; Duan LH; Tong J; Song FF; Fang M; Zheng F; Xiong P; Tan Z; Gong FL
    Int Immunopharmacol; 2010 Jan; 10(1):79-85. PubMed ID: 19818415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
    Xu X; Wei H; Dong Z; Chen Y; Tian Z
    Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.